Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma-Reference-Cited by-同舟云学术

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma

Published:2002-09-05 Issue:6 Volume:95 Page:1279-1285
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Greco F. Anthony,Gray James R.,Thompson Dana S.,Burris Howard A.,Erland Joan B.,Barton John H.,Litchy Sharlene,Houston Gerry A.,Butts James A.,Webb Charles,Scott Charles,Hainsworth John D.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

2. Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non–Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older;Clinical Lung Cancer;2017-09

2. Chemotherapy for advanced non-small cell lung cancer in the elderly population;Cochrane Database of Systematic Reviews;2015-10-20

3. Surfactant-based drug delivery systems for treating drug-resistant lung cancer;Drug Delivery;2014-07-11

4. Gemcitabine and Vinorelbine (GemVin) Regimen;Hospital Pharmacy;2014-06

5. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease;Cochrane Database of Systematic Reviews;2012-04-18